naltrexone oral ReVia
Selected indexed studies
- Overview of Alcohol Use Disorder. (Am J Psychiatry, 2023) [PMID:37525595]
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (JAMA, 2018) [PMID:30167705]
- Renal itch. (Clin Exp Dermatol, 2000) [PMID:10733630]
_Worker-drafted node — pending editorial review._
Connections
naltrexone oral ReVia is a side effect of
Sources
- A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls. (2017) pubmed
- Overview of Alcohol Use Disorder. (2023) pubmed
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) pubmed
- Renal itch. (2000) pubmed
- Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. (2018) pubmed
- Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone. (1997) pubmed
- Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes. (2025) pubmed
- Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review. (2024) pubmed
- Advances in Pharmacotherapy Development: Human Clinical Studies. (2018) pubmed
- Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls. (2020) pubmed